Characterization of tumor cells and stem cells by differential nuclear methylation imaging

Jian Tajbakhsh; Kolja A. Wawrowsky; Arkadiusz Gertych; Ori Bar-Nur; Eugene Vishnevsky; Erik H. Lindsley; Daniel L. Farkas

doi:10.1117/12.769289

28 February 2008 Characterization of tumor cells and stem cells by differential nuclear methylation imaging

Jian Tajbakhsh, Kolja A. Wawrowsky, Arkadiusz Gertych, Ori Bar-Nur, Eugene Vishnevsky, Erik H. Lindsley, Daniel L. Farkas

Author Affiliations +

Proceedings Volume 6859, Imaging, Manipulation, and Analysis of Biomolecules, Cells, and Tissues VI; 68590F (2008) https://doi.org/10.1117/12.769289
Event: SPIE BiOS, 2008, San Jose, California, United States

Abstract

DNA methylation plays a key role in cellular differentiation. Aberrant global methylation patterns are associated with several cancer types, as a result of changes in long-term activation status of up to 50% of genes, including oncogenes and tumor-suppressor genes, which are regulated by methylation and demethylation of promoter region CpG dinucleotides (CpG islands). Furthermore, DNA methylation also occurs in nonisland CpG sites (> 95% of the genome), present once per 80 dinucleotides on average. Nuclear DNA methylation increases during the course of cellular differentiation while cancer cells usually show a net loss in methylation. Given the large dynamic range in DNA methylation load, the methylation pattern of a cell can provide a valuable distinction as to its status during differentiation versus the disease state. By applying immunofluorescence, confocal microscopy and 3D image analysis we assessed the potential of differential nuclear distribution of methylated DNA to be utilized as a biomarker to characterize cells during development and when diseased. There are two major fields that may immediately benefit from this development: (1) the search for factors that contribute to pluripotency and cell fate in human embryonic stem cell expansion and differentiation, and (2) the characterization of tumor cells with regard to their heterogeneity in molecular composition and behavior. We performed topological analysis of the distribution of methylated CpG-sites (MeC) versus heterochromatin. This innovative approach revealed significant differences in colocalization patterns of MeC and heterochromatin-derived signals between undifferentiated and differentiated human embryonic stem cells, as well as untreated AtT20 mouse pituitary tumor cells compared to a subpopulation of these cells treated with 5-azacytidine for 48 hours.

Citation Download Citation

Jian Tajbakhsh, Kolja A. Wawrowsky, Arkadiusz Gertych, Ori Bar-Nur, Eugene Vishnevsky, Erik H. Lindsley, and Daniel L. Farkas "Characterization of tumor cells and stem cells by differential nuclear methylation imaging", Proc. SPIE 6859, Imaging, Manipulation, and Analysis of Biomolecules, Cells, and Tissues VI, 68590F (28 February 2008); https://doi.org/10.1117/12.769289

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available